Sangamo Therapeutics
SGMO
#10419
Rank
HK$0.24 B
Marketcap
HK$0.58
Share price
0.00%
Change (1 day)
-87.47%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of March 2026 : HK$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total debt is HK$0.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$0.20 B-12.14%
2024-12-31HK$0.23 B-20.26%
2023-12-31HK$0.29 B-11.64%
2022-12-31HK$0.33 B-10.16%
2021-12-31HK$0.37 B14.91%
2020-12-31HK$0.32 B-5.66%
2019-12-31HK$0.34 B59.5%
2018-12-31HK$0.21 B12.19%
2017-12-31HK$0.19 B531.79%
2016-12-31HK$30.59 M
2015-12-31N/A
2001-12-31HK$2.22 M
1999-12-31HK$2.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.17 B 284,335.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$449.49 B 296,418.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.45 B 33,843.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$153.91 B 101,436.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$173.87 B 114,601.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$385.14 B 253,970.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$9.98 B 6,485.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.28 B 7,346.72%๐Ÿ‡บ๐Ÿ‡ธ USA